| __timestamp | Amneal Pharmaceuticals, Inc. | CymaBay Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 106735000 | 15823000 |
| Thursday, January 1, 2015 | 136870000 | 17026000 |
| Friday, January 1, 2016 | 204747000 | 15941000 |
| Sunday, January 1, 2017 | 191938000 | 18938000 |
| Monday, January 1, 2018 | 210451000 | 58124000 |
| Tuesday, January 1, 2019 | 202287000 | 83837000 |
| Wednesday, January 1, 2020 | 190585000 | 35882000 |
| Friday, January 1, 2021 | 209563000 | 64542000 |
| Saturday, January 1, 2022 | 200046000 | 67995000 |
| Sunday, January 1, 2023 | 167778000 | 80118000 |
Igniting the spark of knowledge
In the competitive world of pharmaceuticals, research and development (R&D) spending is a key indicator of innovation and future growth. Over the past decade, Amneal Pharmaceuticals, Inc. and CymaBay Therapeutics, Inc. have shown contrasting trends in their R&D investments. From 2014 to 2023, Amneal's R&D expenses have fluctuated, peaking in 2018 with a 97% increase from 2014, before declining by 20% in 2023. In contrast, CymaBay's R&D spending has seen a more consistent upward trajectory, with a remarkable 406% increase from 2014 to 2023. This divergence highlights Amneal's strategic shifts and CymaBay's commitment to innovation. As the pharmaceutical landscape evolves, these spending patterns may offer insights into each company's future market positioning and potential breakthroughs.
R&D Spending Showdown: AstraZeneca PLC vs CymaBay Therapeutics, Inc.
Research and Development Investment: Gilead Sciences, Inc. vs CymaBay Therapeutics, Inc.
Research and Development Investment: Zoetis Inc. vs Amneal Pharmaceuticals, Inc.
Comparing Innovation Spending: Sarepta Therapeutics, Inc. and Amneal Pharmaceuticals, Inc.
R&D Spending Showdown: Axsome Therapeutics, Inc. vs Amneal Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Amneal Pharmaceuticals, Inc. vs CymaBay Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Amneal Pharmaceuticals, Inc. and Xenon Pharmaceuticals Inc.
R&D Spending Showdown: Amneal Pharmaceuticals, Inc. vs PTC Therapeutics, Inc.
Amneal Pharmaceuticals, Inc. vs Protagonist Therapeutics, Inc.: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Amneal Pharmaceuticals, Inc. and MannKind Corporation
Comparing Innovation Spending: Amneal Pharmaceuticals, Inc. and Xencor, Inc.
R&D Insights: How CymaBay Therapeutics, Inc. and Taro Pharmaceutical Industries Ltd. Allocate Funds